Abbott Laboratories R&D expenditure 2004-2022

This statistic shows the expenditure of medical device and pharmaceutical company Abbott in research and development from 2004 to 2022. In 2022, Abbott spent approximately 2.89 billion U.S. dollars on R&D. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott is specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals.

Abbott Laboratories' expenditure on research and development from 2004 to 2022 (in million U.S. dollars)

Characteristic	Investments in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2023

More information

Region

Worldwide

Survey time period

2004 to 2022

Supplementary notes

This statistic was assembled from several Abbott annual and financial reports.
* As of January 1, 2013, Abbott was separated into two companies: Abbott (medical products) and AbbVie (research-based pharmaceuticals). Therefore, from 2013 on only the medical products business is included.

Citation formats